ArticleFrontiers in medicine2026
HPV vaccine hesitancy among Chinese adults and its influencing factors in the context of improved vaccine accessibility.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevention is better than cure: Awareness and acceptance of the HPV vaccine for condyloma acuminata (CA) among college students who self-report no sexual experience.Human vaccines & immunotherapeutics · 2026Article
- Willingness to receive cross-border human papillomavirus vaccination among Chinese male university students: a cross-sectional study with statistical indirect-association analysis.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: HPV vaccination is crucial for preventing HPV-related diseases; however, vaccine hesitancy remains a global challenge. In China, given the increasing vaccine supply and optimized vaccination policies, understanding the current status and determinants of HPV vaccine hesitancy among adults is essential for improving vaccination coverage. Methods: A cross-sectional survey was conducted in China in 2024. Data were collected using a sociodemographic information form, an HPV knowledge questionnaire, the Vaccine Hesitancy Scale, and the WHO Vaccine Hesitancy 3Cs model. Descriptive statistics, chi-square tests, Mann-Whitney U tests, and binary logistic regression were utilized for data analysis. Results: A total of 967 adults participated in this study. The mean age was 33.41 years (SD = 8.71), and 84.4% were women. The overall HPV vaccine hesitancy rate was 19.86%, with 26.5% in men and 18.6% in women. Binary logistic regression analysis revealed that higher complacency, lower confidence and lower HPV knowledge were significant predictors of vaccine hesitancy. Conclusion: HPV vaccine hesitancy among adults is influenced by multiple factors, with higher complacency, lower confidence, and lower HPV knowledge being core issues. Future public health practices should develop personalized intervention strategies focused on improving HPV knowledge, particularly among men and older women. Concurrent efforts should be made to alleviate public complacency and rebuild vaccine confidence by disseminating scientific evidence through multiple channels to address cognitive and attitudinal barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.